Canada’s Health Minister Leona Aglukkaq this week announced that Canada's Food and Drug Regulations have been amended to extend the requirements for Good Manufacturing Practices (GMP) to active pharmaceutical ingredients (APIs) used in medicines. These amendments will come into force in the fall of this year.
"Our Government is committed to protecting the health and safety of Canadians and their families," said Minister Aglukkaq, adding: "That is why we are taking action to improve the safety of Canada's pharmaceutical drug supply."
An API is the ingredient or combination of ingredients in a drug that delivers a health benefit to a patient. An example of a common API is acetaminophen, which is used as a pain reliever. GMPs are an internationally accepted set of standards that help ensure drugs are produced and handled with good quality control.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze